Please login to the form below

Not currently logged in
Email:
Password:

Algeta execs join Targovax

Anna-Kirsti Aksnes and Tina Madsen join the firm

Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.

Anna-Kirsti Aksnes joins the cancer immunotherapy specialist as VP clinical development and Tina Madsen joins as VP quality assurance.

Aksnes was most recently VP clinical research at Algeta, which was taken over by pharma giant Bayer in 2014. In her role she helped lead strategic, scientific, clinical development and medical communications for the company.

Madsen joins as VP quality assurance, joining from the position of director of product quality assurance. She has over 20 years of experience in the life sciences industry.

Commenting on the appointments, Targovax's CEO Gunnar Gardemyr said: “I am pleased to welcome Anne-Kirst and Tina to our team. We look forward to the insight and wealth of experience that they bring to Targovax.”

29th January 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics